BioengineeringACS NanoPeer-reviewed
A Nanoparticle RIG-I Agonist for Cancer Immunotherapy
Lihong Wang-Bishop, Mohamed Wehbe, Lucinda E. Pastora…·John T. Wilson
This paper develops SLR-LNPs, a nanoparticle-based RIG-I agonist, showing enhanced tumor immunogenicity and improved response to immune checkpoint inhibitors in mouse cancer models.
27 citations